ArticleJournal of food science2026
Customer-Oriented Development and Characterization of Spice-Enriched Extruded Breakfast Cereal From Rice Bran and Unripe Banana Flour.
Article in Journal of food science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Developing functional breakfast cereals that are both nutritionally enhanced and consumer-acceptable remains a key challenge for product innovation. This study developed a consumer-oriented, spice-enriched extruded breakfast cereal formulated by partially substituting corn grits with rice bran and unripe banana flour, with product optimization guided primarily by sensory evaluation. Four formulations containing 0%-3% of a spice blend (ginger, cinnamon, and lemongrass) were produced using extrusion cooking and evaluated under three serving conditions (without milk, with cold milk, and with warm milk). Product development followed a three-step approach. First, sensory differences among formulations were assessed using Check-All-That-Apply (CATA), Rate-All-That-Apply (RATA), and hedonic rating tests, revealing significant variations in aroma, taste, and aftertaste attributes. Across serving conditions, the formulation containing 1% spice achieved the highest overall liking (p < 0.001 without milk; p < 0.05 with warm milk). Functional characterization showed that increasing spice levels significantly enhanced total phenolic content (17.53-29.16 mg GAE/g), total flavonoid content (9.51-26.96 mg QE/g), and antioxidant activity (6.08-103.36 mg TE/g ABTS; 4.25-30.74 mg TE/g DPPH) (p < 0.001). Second, the optimal formulation was identified using Bayesian multi-criteria decision analysis integrating sensory acceptance with nine physicochemical parameters, confirming the 1% spice blend (SB) as optimal. Third, the selected formulation was further characterized for glycemic response. The glycemic index of the optimized product was 47 ± 8, categorizing it as a low-glycemic food. These findings demonstrate that modest spice incorporation can maintain consumer preference while improving functional properties, supporting the development of healthier extruded cereal products. PRACTICAL APPLICATIONS: This study provides a practical framework for developing spice-enriched extruded breakfast cereal (SEBC) using rice bran and unripe banana flour while maintaining consumer acceptance. The consumer-oriented product development approach enables food manufacturers to optimize spice levels to achieve a desirable balance between flavor, texture, and functional properties without compromising consumer acceptance. The study further demonstrates the feasibility of converting underutilized agricultural by-products (i.e., rice bran and unripe banana flour) into commercially viable, functional cereal products with improved nutritional attributes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.